Target intelligence / Profile preview

High mobility group nucleosomal binding domain 2 pseudogene 41 (HMGN2P41)

Target
HMGN2P41
Molecular classification
Other (Pseudogene)
01

Overview

High mobility group nucleosomal binding domain 2 pseudogene 41 (HMGN2P41) is a human pseudogene, derived as a retrocopy of the parental gene HMGN2. Located on chromosome 15, HMGN2P41 contains sequence homology to HMGN2 but does not encode a functional protein product[9]. Pseudogenes, including HMGN2P41, are defined by the lack of protein-coding capability but can sometimes be transcribed and exert regulatory functions such as acting as microRNA decoys or through other non-coding RNA-based mechanisms[6][8]. However, there are no known biological functions, drug interactions, or clinical roles specifically attributed to HMGN2P41 at this time[3][5][7][9]. It is not recognized as a receptor, enzyme, transporter, or any other category of therapeutic target. Key facts: - HMGN2P41 is not a protein-coding gene but a processed pseudogene (retrocopy of HMGN2)[9]. - It does not have known therapeutic relevance or established functional roles. - Pseudogenes as a class can sometimes have biological activities (such as transcript-based regulation), but this is not established for HMGN2P41[2][4]. Summary: HMGN2P41 is a nonfunctional DNA sequence related to the high mobility group nucleosomal binding domain 2 gene, best classified under "Other" (pseudogene) and is not a canonical therapeutic or druggable target[3][5][7][9].

02

Mechanism of action

None (no targeted mechanism, as it is not an active gene product or direct drug target[7][9])

03

Biological functions

Other (pseudogenes in general may regulate gene expression via RNA-mediated mechanisms, but HMGN2P41 itself has no uniquely assigned biological function[3][5][7][9])
04

Disease associations

Other (no evidence for a disease role, but pseudogenes as a class can have regulatory roles in some cancers or other conditions[2][4])

Beyond the preview

Go deeper on High mobility group nucleosomal binding domain 2 pseudogene 41 (HMGN2P41).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosomal binding domain 2 pseudogene 41 (HMGN2P41).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call